Laura Maracci

Efficacy and tolerability of bendamustine, bortezomib and dexamethasone in patients with relapsed-refractory multiple myeloma: a phase II study

Massimo Offidani, Laura Corvatta, Laura Maracci et al. · Blood Cancer Journal · 2013 · 61 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

Bloodstream infections caused by Escherichia coli in onco-haematological patients: Risk factors and mortality in an Italian prospective survey

Enrico Maria Trecarichi, Gabriele Giuliano, Chiara Cattaneo et al. · PLoS ONE · 2019 · 50 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +16

Bloodstream infections due to Gram-negative bacteria in patients with hematologic malignancies: updated epidemiology and risk factors for multidrug-resistant strains in an Italian perspective survey

Enrico Maria Trecarichi, Gabriele Giuliano, Chiara Cattaneo et al. · International Journal of Antimicrobial Agents · 2023 · 33 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +16

‘Real-life’ analysis of the role of antifungal prophylaxis in preventing invasive aspergillosis in AML patients undergoing consolidation therapy: Sorveglianza Epidemiologica Infezioni nelle Emopatie (SEIFEM) 2016 study

Maria Ilaria Del Principe, Giulia Dragonetti, Luisa Verga et al. · Journal of Antimicrobial Chemotherapy · 2018 · 16 citations · Full text

Medicine, Infectious Diseases, Internal Medicine +15

Long Term Outcome of Lenalidomide-Dexamethasone (Rd) Vs Melphalan-Lenalidomide-Prednisone (MPR) Vs Cyclophosphamide-Prednisone-Lenalidomide (CPR) As Induction Followed By Lenalidomide-Prednisone (RP) Vs Lenalidomide (R) As Maintenance in a Community-Based Newly Diagnosed Myeloma Population: Updated Analysis of EMN01 Phase III Study

Sara Bringhen, Massimo Offidani, Pellegrino Musto et al. · Blood · 2017 · 11 citations

Medicine, Hematology, Oncology +14